1. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs;Bromley;J. Neurol. Neurosurg. Psychiatry,2013
2. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism;Christensen;JAMA,2013
3. The fetal valproate syndrome;DiLiberti;Am. J. Med. Genet.,1984
4. Elger, C.E., Berkenfeld, R., 2017. S1-Leitlinie Erster epileptischer Anfall und Epilepsien im Erwachsenenalter, in: Deutsche Gesellschaft für Neurologie (Ed.), Leitlinien für Diagnostik und Therapie in der Neurologie.
5. European Medicines Agency, 2014. PRAC recommends strengthening the restrictions on the use of valproate in women and girls. Women to be better informed of the risks of valproate use during pregnancy. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Valproate_and_related_substances_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500175214.pdf (accessed 27.04.2017).